Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

50.0%

-36.6% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(3)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07605546Not ApplicableRecruiting

RAD ONC FREEDOM Oncology Pain

Role: collaborator

NCT05891002Terminated

Accuracy of Robotically Assisted Cranial Biopsies

Role: lead

NCT05504681Recruiting

Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Role: collaborator

NCT05545007Not ApplicableRecruiting

Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases

Role: collaborator

NCT06204315Phase 2Recruiting

Risk Adapted Spinal Cord/Cauda Constraint Relaxation for High-risk Patients With Metastatic Epidural Spinal Cord Compression Undergoing Spine Stereotactic Radiosurgery

Role: collaborator

NCT07468370Not Yet Recruiting

Real Time Craniotomy Planning Using Mixed Reality

Role: lead

NCT06903260Phase 3Completed

Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study)

Role: collaborator

NCT05956977Not ApplicableUnknown

Evaluation of 3D Ultrasound in Brain Tumor Surgery

Role: collaborator

All 8 trials loaded